Literature DB >> 31777459

Polyp Genetics.

Coen Laurens Klos1, Sekhar Dharmarajan1.   

Abstract

The genetic events involved in the transformation of normal colonic epithelium to neoplastic polyps to invasive carcinoma, as initially proposed by Fearon and Vogelstein, form the foundation of our understanding of colorectal cancer. The identification of the polyp as the precursor lesion to colorectal cancer is the basis of many of our current practices for screening, surveillance, and prevention. The last three decades have seen a veritable explosion in our understanding of the molecular events involved in the pathogenesis of colorectal cancer. It is now clear that there are multiple genetic pathways in the polyp to carcinoma sequence. Some polyps previously thought to be nonneoplastic have now been shown to have malignant potential. Finally, increased understanding of the sequence of genetic events has led to the development of targeted therapeutics. The clinical translation of these scientific advances has made a significant impact on the management of patients with colorectal cancer. Accordingly, it is imperative that all clinicians caring for these patients have an understanding of the genetics of colorectal polyps and cancer. In this article, we review the etiology and genetic pathways to carcinoma associated with a range of polyps of the colon and rectum. © Thieme Medical Publishers.

Entities:  

Keywords:  colorectal; genetics; neoplasm; polyps

Year:  2016        PMID: 31777459      PMCID: PMC6878828          DOI: 10.1055/s-0036-1582442

Source DB:  PubMed          Journal:  Clin Colon Rectal Surg        ISSN: 1530-9681


  39 in total

Review 1.  Traditional serrated adenoma: an update.

Authors:  Mark L Bettington; Runjan Chetty
Journal:  Hum Pathol       Date:  2015-04-20       Impact factor: 3.466

Review 2.  Lessons from hereditary colorectal cancer.

Authors:  K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1996-10-18       Impact factor: 41.582

3.  Prevalence and characteristics of serrated lesions of the colorectum in Italy: A multicentre prospective cohort study.

Authors:  Gianluca Rotondano; Maria Antonia Bianco; Livio Cipolletta; Riccardo Marmo
Journal:  Dig Liver Dis       Date:  2015-03-14       Impact factor: 4.088

4.  Morphologic and molecular characterization of traditional serrated adenomas of the distal colon and rectum.

Authors:  Homer O Wiland; Bonnie Shadrach; Daniela Allende; Paula Carver; John R Goldblum; Xiuli Liu; Deepa T Patil; Lisa A Rybicki; Rish K Pai
Journal:  Am J Surg Pathol       Date:  2014-09       Impact factor: 6.394

Review 5.  Molecular pathology of colorectal cancer.

Authors:  Ft Bosman; P Yan
Journal:  Pol J Pathol       Date:  2014-12       Impact factor: 1.072

6.  Epidemiology of goblet cell and microvesicular hyperplastic polyps.

Authors:  Taha M Qazi; Michael J O'Brien; Francis A Farraye; Ryan W Gould; Clara A Chen; Paul C Schroy
Journal:  Am J Gastroenterol       Date:  2014-10-28       Impact factor: 10.864

Review 7.  Epidermal growth factor receptor monoclonal antibodies for the treatment of metastatic colorectal cancer.

Authors:  Gary W Jean; Sachin R Shah
Journal:  Pharmacotherapy       Date:  2008-06       Impact factor: 4.705

Review 8.  Prevalence of adenomas and colorectal cancer in average risk individuals: a systematic review and meta-analysis.

Authors:  Steven J Heitman; Paul E Ronksley; Robert J Hilsden; Braden J Manns; Alaa Rostom; Brenda R Hemmelgarn
Journal:  Clin Gastroenterol Hepatol       Date:  2009-06-10       Impact factor: 11.382

Review 9.  Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review.

Authors:  Łukasz Szylberg; Marlena Janiczek; Aneta Popiel; Andrzej Marszałek
Journal:  Gastroenterol Res Pract       Date:  2015-04-07       Impact factor: 2.260

Review 10.  Biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer.

Authors:  Salvatore Siena; Andrea Sartore-Bianchi; Federica Di Nicolantonio; Julia Balfour; Alberto Bardelli
Journal:  J Natl Cancer Inst       Date:  2009-09-08       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.